Success Metrics

Clinical Success Rate
97.1%

Based on 34 completed trials

Completion Rate
97%(34/35)
Active Trials
7(14%)
Results Posted
3%(1 trials)
Terminated
1(2%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

97.1%

34 of 35 finished

Non-Completion Rate

2.9%

1 ended early

Currently Active

7

trials recruiting

Total Trials

51

all time

Status Distribution
Active(10)
Completed(34)
Terminated(1)
Other(6)

Detailed Status

Completed34
unknown6
Recruiting5
Not yet recruiting3
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
51
Active
7
Success Rate
97.1%

Trials by Status

unknown612%
completed3467%
active_not_recruiting24%
recruiting510%
not_yet_recruiting36%
terminated12%

Recent Activity

Clinical Trials (51)

Showing 20 of 51 trialsScroll for more
NCT06170671

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

Active Not Recruiting
NCT04590950

Dosage and PD Study of Eftrenonacog-alfa

Completed
NCT05437250

National Acalabrutinib Observational Study

Active Not Recruiting
NCT07291479

Behavioral Assessment Method Index

Recruiting
NCT06906380

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Not Yet Recruiting
NCT05213429

Middle East Coronary Artery Ectasia Registry

Recruiting
NCT06904547

Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC

Not Yet Recruiting
NCT06888180

Survey on NIV Settings in the Intensive Care Unit for Acute Exacerbation of COPD

Not Yet Recruiting
NCT06749015

A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)

Recruiting
NCT03350607

" Sweeper " and Epiretinal Membrane Surgery

Completed
NCT06328075

Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis

Recruiting
NCT03467529

Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study

Completed
NCT04807712

Pediatric Pertussis in Ambulatory Settings

Recruiting
NCT03345537

Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein

Completed
NCT02792205

Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding

Completed
NCT03234166

Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis

Completed
NCT04632173

Head and Neck cancERs International cOviD-19 collabOraTion

Unknown
NCT02847052

Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease

Terminated
NCT04067739

ICU Readmission in Adult Egyptian Patients Undergoing Living Donor Liver Transplant

Completed
NCT03421392

Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICT

Completed

Drug Details

Intervention Type
OTHER
Total Trials
51